Tirpezatide: Anti-Obesity agents, adjunct to reduced-calorie diet & increased physical activity for weight management, including weight loss & maintenance in adults with initial BMI of >= 30 mg/m2 (obesity) or >= 27 to <30 kg/m2 (overweight) in the presence of at least one related comorbid condition (eg, HTN, dyslipidemia, obstructive sleep apnea, CV disease, prediabetes, or type 2 DM)
Mounjaro 2.5 mg/0.6 mL (4 doses)
11 000,00 THBPrix
){kind=link}